Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Abstract

Multi-Criteria Decision Analysis (MCDA) has been proposed as appropriate methodology for supporting many key decisions in the drug lifecycle, including regulatory authorization, health technology assessment (HTA) and prescription. The relevant decision criteria are different in these three settings: regulatory MCDAs are mostly concerned with assessing treatment benefit-risk profiles, prescription ones additionally consider convenience and patient satisfaction, and HTAs value cost and equity aspects. This presentation will question whether any single methodology can support decisions as diverse as these, but it will also argue for the value of MCDA as a general framework for structuring comparative treatment assessments. I will demonstrate the use of MCDA in benefit-risk assessment, discuss flaws present in most applications of MCDA in HTA, and argue against application of MCDA in prescription setting.

Biography

Dr. Tommi Tervonen is a Research Scientist at the Patient Preference Team of Patient-Centered Research group of Evidera, a for-profit consultancy. In his role, he serves as a principal investigator in health preference research projects. Before joining Evidera in 2015 he was an assistant professor at the Erasmus School of Economics in Rotterdam, and has held a post of visiting professor at the Systems Analysis Laboratory of Aalto University, Helsinki. He currently serves as an associate editor of Decision Support Systems. In the past, he has acted as a reviewer for the European Commission’s 2015–2019 policy impact assessment guidelines. Tommi holds a double-degree PhD (with distinction) in computer science from University of Turku (Finland) and in management science from University of Coimbra (Portugal).

Forthcoming events

Richard Doll Seminar - Some contemporary insights into cardio-vascular risk

Tuesday, 18 June 2019, 1pm to 3pm @ Seminar rooms, BDI, Old Road Campus, OX3 7LF

Ethox and WEH Seminar - Ethical preparedness and genomics in the headlines

Wednesday, 26 June 2019, 11am to 12.30pm @ Seminar room 0, BDI, Old Road Campus, OX3 7LF

HERC Seminar - Quality of Life Trajectories in Total knee Replacement Patients: What can they tell us?

Thursday, 27 June 2019, 1pm to 2pm @ Seminar room 0, BDI, Old Road Campus, OX3 7LF

Richard Doll Seminar - The ASPREE Study: The use of aspirin in older people without cardiovascular disease

Monday, 01 July 2019, 1pm to 2pm @ Richard Doll Lecture Theatre, Richard Doll Building, Old Road Campus, OX3 7LF

NPEU Research Seminar - Women and cardiovascular disease: an odd couple?

Tuesday, 09 July 2019, 10.30am to 11.30am @ Lecture Theatre, Richard Doll Building, Old Road Campus, OX3 7LF